tiprankstipranks
Trending News
More News >
Indo Rama Synthetics (India) Limited (IN:INDORAMA)
:INDORAMA
India Market

Indo Rama Synthetics (India) Limited (INDORAMA) AI Stock Analysis

Compare
0 Followers

Top Page

IN:INDORAMA

Indo Rama Synthetics (India) Limited

(INDORAMA)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
₹32.00
▼(-33.87% Downside)
Action:ReiteratedDate:02/25/26
The score is driven by a mixed financial picture: improving revenue and a return to positive free cash flow are supportive, but very weak profitability and high leverage materially raise risk. Technically, the stock is in a clear downtrend and remains oversold, which weighs on the near-term outlook. Valuation is a modest offset due to the low P/E.
Positive Factors
Revenue Recovery
Sustained revenue growth and a higher gross margin indicate improving demand and better cost management across polyester and films. Over 2-6 months this underpins capacity utilization, spreads fixed costs and supports incremental operating leverage as volumes stabilize.
Positive Free Cash Flow
A return to positive free cash flow demonstrates the company's ability to convert earnings into cash, strengthening liquidity. This durable improvement supports debt servicing, targeted capex and potential balance-sheet repair without relying on external financing.
Integrated product portfolio
Vertical integration and diversified end markets (textiles and packaging films) reduce feedstock pass-through risk and enable internal optimization of polyester chips. This structural mix provides pricing and operational flexibility across cycles and supports cross-segment resilience.
Negative Factors
High Leverage
Very high leverage constrains financial flexibility and raises refinancing and interest-rate risk. Over the medium term elevated debt limits capacity to absorb shocks, forces larger interest burdens and prioritizes cash for creditors over reinvestment or strategic initiatives.
Thin Profitability
Persistently low operating and net margins leave limited buffer against raw-material swings or pricing pressure. Structurally thin profitability reduces retained earnings growth, hampers ROE improvement and makes deleveraging and capital allocation more difficult.
Volatile cash-flow history
Although FCF is positive now, prior negative cash flows show volatility in cash generation. This inconsistency complicates multi-period planning, raises execution risk for debt reduction and capex, and means recent improvement may be fragile without structural change.

Indo Rama Synthetics (India) Limited (INDORAMA) vs. iShares MSCI India ETF (INDA)

Indo Rama Synthetics (India) Limited Business Overview & Revenue Model

Company DescriptionIndo Rama Synthetics (India) Limited manufactures and supplies polyester in India. The company offers various polyester products, including polyester staple fiber, polyester filament yarn, draw texturized yarn, fully drawn yarn, and polyester chips. Its products are used in various applications, such as apparel and sportswear, home furnishings and textiles, hygiene and non-woven, and automotive. The company also operates in the Middle East and North Africa, Turkey, Brazil, Argentina, Mexico, Columbia, Germany, Belgium, Portugal, Spain, Poland, Italy, Bangladesh, and Nepal. Indo Rama Synthetics (India) Limited was incorporated in 1986 and is based in Gurugram, India.
How the Company Makes MoneyINDORAMA primarily makes money by manufacturing and selling synthetic polymer-based products across two main business lines: (1) polyester intermediates and textiles (PSF, POY, DTY, and polyester chips) and (2) packaging films (BOPP films). Revenue is generated through sales volumes multiplied by realizations (selling prices) for each product category to downstream industrial customers. In the polyester segment, polyester chips are sold as an intermediate feedstock and also consumed internally to produce fibres and yarns; PSF is typically sold to spinners and nonwoven/filling applications, while POY and DTY are sold to textile processors for fabric production. In the BOPP films segment, the company sells film grades used by converters and packaging companies for lamination, printing, and labeling applications. Earnings are influenced by product mix, capacity utilization, and the spread between polymer/feedstock input costs and finished-product selling prices. Specific details on major customers, long-term offtake agreements, or named strategic partnerships are null.

Indo Rama Synthetics (India) Limited Financial Statement Overview

Summary
Financials show recovery but remain fragile. Revenue rose 15.23% and gross margin improved to 21.2%, while free cash flow turned positive (3.52B). Offsetting this, profitability is extremely thin (net margin 0.03%, EBITDA margin 4.2%) and leverage is high (debt-to-equity 3.09; equity ratio 12.5%).
Income Statement
45
Neutral
Indo Rama Synthetics shows mixed performance in its income statement. The company experienced a significant recovery in revenue from 2024 to 2025, with a revenue growth rate of 15.23%. Gross profit margin improved to 21.2% in 2025, indicating better cost management. However, the net profit margin remains weak at 0.03% in 2025, primarily due to past losses and fluctuating EBIT margins. The EBITDA margin of 4.2% shows limited operating efficiency, highlighting the need for further profitability improvement.
Balance Sheet
50
Neutral
The balance sheet indicates high leverage with a debt-to-equity ratio of 3.09 in 2025, which poses financial risk. The equity ratio is low at 12.5%, suggesting potential vulnerability in financial stability. Return on Equity (ROE) improved to 0.38% due to a small net income, but still remains low. The company must focus on reducing debt levels and improving equity to enhance financial stability.
Cash Flow
60
Neutral
Cash flow analysis reveals a substantial improvement with positive free cash flow of 3.52 billion in 2025. The operating cash flow to net income ratio is strong, reflecting effective cash generation from operations. However, the free cash flow growth rate is not calculable due to negative values in previous years, indicating a volatile cash flow history. Continued focus on maintaining positive cash flows is essential for financial health.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue48.90B42.59B36.96B39.33B40.38B20.43B
Gross Profit10.65B9.03B3.95B493.60M5.08B5.84B
EBITDA3.07B1.79B-327.10M662.00M3.02B1.03B
Net Income1.42B14.00M-2.03B-245.60M2.69B1.13B
Balance Sheet
Total Assets29.71B29.36B29.07B27.13B21.05B17.11B
Cash, Cash Equivalents and Short-Term Investments82.90M300.40M293.70M614.00M123.20M93.80M
Total Debt10.94B11.36B13.39B8.90B3.58B3.95B
Total Liabilities25.26B25.67B25.39B21.40B15.06B13.78B
Stockholders Equity4.46B3.68B3.68B5.73B5.99B3.33B
Cash Flow
Free Cash Flow814.70M3.52B-3.57B-4.46B1.20B1.56B
Operating Cash Flow914.60M3.91B-967.30M-809.90M2.00B1.82B
Investing Cash Flow-53.30M-363.40M-2.58B-3.48B-754.40M-175.00M
Financing Cash Flow-1.06B-3.54B3.22B4.79B-1.23B-1.74B

Indo Rama Synthetics (India) Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price48.39
Price Trends
50DMA
38.18
Negative
100DMA
45.84
Negative
200DMA
49.52
Negative
Market Momentum
MACD
-1.99
Negative
RSI
31.07
Neutral
STOCH
24.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDORAMA, the sentiment is Negative. The current price of 48.39 is above the 20-day moving average (MA) of 33.88, above the 50-day MA of 38.18, and below the 200-day MA of 49.52, indicating a bearish trend. The MACD of -1.99 indicates Negative momentum. The RSI at 31.07 is Neutral, neither overbought nor oversold. The STOCH value of 24.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDORAMA.

Indo Rama Synthetics (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹8.01B22.241.23%0.69%-7.54%
58
Neutral
₹8.87B36.692.08%4.65%-127.24%
56
Neutral
₹8.64B-20.110.56%16.82%
52
Neutral
₹8.26B36.1130.79%
46
Neutral
₹5.85B-2,425.331.07%-22.10%-85.56%
46
Neutral
₹8.06B-127.170.17%12.25%-74.52%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:INDORAMA
Indo Rama Synthetics (India) Limited
31.65
-4.06
-11.37%
IN:ESTER
Ester Industries Limited
88.55
-40.78
-31.53%
IN:FAIRCHEMOR
Fairchem Organics Ltd
464.45
-504.52
-52.07%
IN:JAYAGROGN
Jayant Agro-Organics Limited
166.30
-75.13
-31.12%
IN:OAL
Oriental Aromatics Ltd.
239.60
-69.21
-22.41%
IN:TNPL
Tamil Nadu Newsprint & Papers Ltd.
128.10
0.60
0.47%

Indo Rama Synthetics (India) Limited Corporate Events

Indo Rama Synthetics Clears Q3 Results and Reshapes Board, Audit Committee
Jan 31, 2026

Indo Rama Synthetics (India) Limited’s board met on 31 January 2026 and approved the unaudited standalone and consolidated financial results for the third quarter and nine months ended 31 December 2025, along with noting unmodified limited review reports from its statutory auditors. The company will publish extracts of these results and has also announced significant board and governance changes, including the resignations of non-executive director Dilip Kumar Agarwal and whole-time director Sanjay Thapliyal, the appointments of Vipin Kumar as a non-executive non-independent additional director and Sanjay Gupta as an executive additional director, revised authorisation of key managerial personnel for regulatory disclosures, and the reconstitution of the audit committee to reflect the new board composition.

India Ratings Revises Indo Rama Synthetics’ Outlook to Stable, Affirms Bank Loan Ratings
Jan 27, 2026

India Ratings and Research, part of the Fitch Group, has revised the outlook on Indo Rama Synthetics (India) Limited’s existing bank loan facilities totaling INR 16,200 million to Stable from Negative, while affirming the ratings at IND A- for long-term and IND A2+ for short-term instruments. In addition, a new INR 1,000 million bank loan facility has been assigned the same IND A-/Stable and IND A2+ ratings, signaling an improvement in the agency’s view of the company’s credit profile and funding stability, which may support Indo Rama’s access to bank financing and bolster confidence among lenders and other financial stakeholders.

Indo Rama Synthetics Reports No Re-Lodgement Requests for Physical Share Transfers
Jan 12, 2026

Indo Rama Synthetics (India) Limited has informed the stock exchanges that, pursuant to a SEBI circular providing a special window for re-lodgement of transfer requests for physical share certificates, it did not receive any such requests from shareholders during November and December 2025 and up to 6 January 2026. The company’s registrar and share transfer agent, MCS Share Transfer Agent Limited, confirmed that there were zero requests received, processed, approved or rejected in the relevant period, indicating that shareholders have largely transitioned away from physical share transfers or had no pending issues requiring re-lodgement under this special regulatory window.

Indo Rama Synthetics Receives GST Demand Order of Over Rs 1 Crore for FY 2022
Dec 30, 2025

Indo Rama Synthetics (India) Limited has disclosed that it has received an order from the Maharashtra Goods and Service Tax Department, Office of the Deputy Commissioner of State Tax in Nagpur, determining dues under Section 73 of the MGST/CGST Act, 2017. The order, received on 29 December 2025, seeks recovery of Rs 1,01,15,356 for financial year 2021-22, covering tax, interest and penalty, arising from alleged discrepancies and unreconciled reverse charge mechanism liability on freight and carriage expenses. The company has stated that the financial impact will depend on the outcome of the ongoing proceedings, indicating potential exposure but no immediate quantified effect on its operations beyond this contingent liability.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 25, 2026